BREAKING
ZTO Express Fiscal Year 2025 Financial Review 7 hours ago Modiv Industrial (MDV) Declares $0.29 Monthly Dividend With 8.23% Yield, Ex-Date March 31 8 hours ago Fifth Third Bancorp (FITB) Declares $0.40 Quarterly Dividend, 3.68% Yield; Ex-Date March 31 8 hours ago Titan Machinery (TITN) Reports Wider Q4 Loss of $1.43/Share vs $0.63 Estimate Despite Revenue Beat 9 hours ago Aveanna Healthcare Reports Strong 2025 Financial Results 10 hours ago Tejon Ranch (TRC) Q4 Revenue Surges 29.9% to $23.3M, Beating Estimates by 67.6% 10 hours ago Duluth Trading Company Q4 Financial Update 10 hours ago Lands’ End (LE) Q4 EPS Beats by 27.3% at $0.76, Revenue Misses at $462.4M 10 hours ago Hello Group (MOMO) Misses Q4 EPS by 84.3% as Revenue Plunges 86.0% Year-Over-Year 10 hours ago Williams-Sonoma, Inc. Fiscal 2025 Financial Performance 11 hours ago ZTO Express Fiscal Year 2025 Financial Review 7 hours ago Modiv Industrial (MDV) Declares $0.29 Monthly Dividend With 8.23% Yield, Ex-Date March 31 8 hours ago Fifth Third Bancorp (FITB) Declares $0.40 Quarterly Dividend, 3.68% Yield; Ex-Date March 31 8 hours ago Titan Machinery (TITN) Reports Wider Q4 Loss of $1.43/Share vs $0.63 Estimate Despite Revenue Beat 9 hours ago Aveanna Healthcare Reports Strong 2025 Financial Results 10 hours ago Tejon Ranch (TRC) Q4 Revenue Surges 29.9% to $23.3M, Beating Estimates by 67.6% 10 hours ago Duluth Trading Company Q4 Financial Update 10 hours ago Lands’ End (LE) Q4 EPS Beats by 27.3% at $0.76, Revenue Misses at $462.4M 10 hours ago Hello Group (MOMO) Misses Q4 EPS by 84.3% as Revenue Plunges 86.0% Year-Over-Year 10 hours ago Williams-Sonoma, Inc. Fiscal 2025 Financial Performance 11 hours ago
ADVERTISEMENT
HALO

Halozyme Therapeutics, Inc

$HALO NASDAQ Mar 3, 2026 DMH FY 2026

Investor Toolbox

Listen to Call

Watch or listen to the earnings call recording.

Open Webcast

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

HALO Coverage

Event Halozyme Therapeutics, Inc (HALO) Sec Form 8K Mar 13, 2026 Event Halozyme Therapeutics, Inc (HALO) Halozyme Appoints David Ramsay as Interim Chief Financial Officer Mar 12, 2026 Transcript Halozyme Therapeutics, Inc (HALO) Q4 2025 Earnings Call Transcript Mar 10, 2026 Event Halozyme Therapeutics, Inc (HALO) U.S. FDA Approves TECVAYLI® in Combination with DARZALEX FASPRO® for Relapsed/Refractory Multiple Myeloma Mar 6, 2026 News Halozyme Q4 2025 Earnings Surge: Royalty Revenue Soars 52% Feb 17, 2026 Transcript Halozyme Therapeutics, Inc (HALO) Q2 2025 Earnings Call Transcript Jan 22, 2026 Transcript Halozyme Therapeutics, Inc (HALO) Q3 2025 Earnings Call Transcript Jan 22, 2026